Neoadjuvant chemotherapy in locally advanced cervical cancer

Australian and New Zealand Journal of Medicine

Volumn 28, Issue 3, 1998, Pages 387-390

  Kumar, L ^a   Grover, R ^a   Pokharel, Y H ^a   Chander, S ^a   Kumar, S ^a   Singh, R ^a   Rath, G K ^a   Kochupillai, V ^a  

^a INSTITUTE ROTARY CANCER HOSPITAL   (India)

Author keywords

Locally advanced cervical cancer; Neoadjuvant chemotherapy; Radiotherapy

Indexed keywords

BLEOMYCIN; CISPLATIN; IFOSFAMIDE; MESNA;

ALOPECIA; BONE MARROW SUPPRESSION; CANCER ADJUVANT THERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; GASTROINTESTINAL TOXICITY; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MUCOSA INFLAMMATION; RANDOMIZED CONTROLLED TRIAL; SQUAMOUS CELL CARCINOMA; TREATMENT OUTCOME; UTERINE CERVIX CARCINOMA;

EID: 0031829720     PISSN: 00048291     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1445-5994.1998.tb01970.x     Document Type: Conference Paper

References (16)

1. Cannistra SA, Niloff JM. Cancer of the uterine cervix. N Engl J Med 1996; 334: 1030-8.
2. Omura GA. Chemotherapy for cervix cancer. Semin Oncol 1994; 21: 54-62.
3. Kumar L, Bhargava VL. Chemotherapy in recurrent and advanced cervical cancer. Gynecol Oncol 1991; 40: 107-11.
4. Kumar I, Kaushal R, Nandy M et al. Chemotherapy followed by radiotherapy versus radiotherapy in locally advanced cervical cancer: A randomized study. Gyn Oncol 1994; 54: 307-15.
5. Miller AB, Hoogstraten B, Staquet M, Winkler A. Reporting the results of cancer treatment. Cancer 1981; 47: 207-11.
6. Kuhnle H, Meerpohl HG, Eiermann W, Roben S, Lenaz L, Achterrath W. Phase II study of carboplatin/ifosfamide in untreated cervical cancer. Cancer Chemo Pharmacol 1990; 26: 33-5.
7. Lara PC, Garcia Puche JI, Pedraza V. Cisplatin -ifosfamide as neoadjuvant chemotherapy in stage III B cervical uterine squamous cell carcinoma. Cancer Chemo Pharmacol 1990; 26: 36-8.
8. Tobias J, Buxton FJ, Blackledge G et al. Neoadjuvant bleomycin, ifosfamide and cisplatin in cervical cancer. Cancer Chemo Pharmacol 1990; 26: 59-62.
9. Panici PB, Scambia G, Baiocchi G et al. Neoadjuvant chemotherapy and radical surgery in locally advanced cervical cancer. Prognostic factors for response and survival. Cancer 1991; 67: 372-9.
10. Leone B, Vallejo C, Perez J et al. Ifosfamide and cisplatin as neoadjuvant chemotherapy for advanced cervical carcinoma. Am J Clin Oncol 1996; 19: 132-5.
11. Souhami L, Gil RA, Allan S et al. Randomized trial of chemotherapy followed by pelvic radiotherapy versus radiotherapy alone in stage III B carcinoma of the cervix. J Clin Oncol 1991; 9: 970-7.
12. Cardens J, Olguin A, Figueroa F, Bercerra F, Huizar RM. Randomized neoadjuvant chemotherapy in cervical cancer stage II B: PEC+RT vs RT. Proc Annual Meet Am Soc Clin Oncol 1991; 10: A620.
13. Sardi J, Sananes C, Giaroli A et al. Results of a prospective randomized trial with neoadjuvant chemotherapy in stage IB, bulky, squamous carcinoma of cervix. Gynecol Oncol 1993; 49: 156-65.
14. Tattersall MHN, Lorvidhaya V, Voodprux V et al. Randomized trial of epirubicin and cisplatin chemotherapy followed by pelvic radiation in locally advanced cervical cancer. J Clin Oncol 1995; 13: 444-51.
15. Lippman SM, Kavanagh JJ, Paredes-Espinoza M et al. 13 cis-retinoic acid plus interferon-2a: highly active systemic therapy for squamous cell carcinoma of cervix. J Natl Cancer Inst 1992; 84: 241-5.
16. Rose PG. Locally advanced cervical carcinoma: the role of chemoradiation. Semin Oncol 1994; 21: 47-53.